Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Innovent Announces First Patient Dosed in Anti-CD47 Trial

americanpharmaceuticalreviewJanuary 16, 2019

Tag: Innovent , Anti-CD47 Trial , advanced malignancies , cancer immunotherapy

PharmaSources Customer Service